Article Per Year (5 Year)
p-Index From 2021 - 2026
0.23
P-Index
This Author published in this journals
All Journal Jimstek
Irfan Al Fahmi
Universitas Sahid Surakarta
Chemical Engineering, Chemistry & Bioengineering Chemistry Computer Science & IT Control & Systems Engineering Decision Sciences, Operations Research & Management Earth & Planetary Sciences Electrical & Electronics Engineering Energy Engineering Health Professions Industrial & Manufacturing Engineering Materials Science & Nanotechnology Mechanical Engineering Medicine & Pharmacology Neuroscience Nursing Physics Public Health Veterinary

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
Gambaran Penggunaan Obat Pada Pasien Diabetes Mellitus Tipe 2 DI Intalasi Rawat Jalan RS dr. Oen Solo Baru Periode Januari-Juni 2023 Irfan Al Fahmi; Risma Sakti Pambudi; Khotimatul Khusna
JIMSTEK: Jurnal Ilmiah Sains dan Teknologi Vol. 6 No. 01 (2024): JIMSTEK: Jurnal Ilmiah Sains dan Teknologi
Publisher : Fakultas Sains, Teknologi dan Kesehatan Universitas Sahid Surakarta

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Diabetes mellitus (DM) is a widespread health problem and continues to increase every year. Management of DM involves implementing a healthy lifestyle, increasing physical activity, and pharmacological therapy. The aim of this research was to determine the description of drug use in patients with type 2 diabetes mellitus in the outpatient installation of Dr. Hospital. Oen Solo Baru for the period January-June 2023. This research is a non-experimental descriptive research design where data is collected retrospectively. Data analysis uses quantitative research which is presented in the form of a table of number of cases and percentage (%). The number of samples in this study was 100 medical record data. The results of the study showed that there were 5 types of antihyperglycemia drugs used, namely the Sulfonylurea group with (42%), Biguanid (28%), Insulin (12%), DPP-4 Inhibitors (10%), and α-glucosidase Inhibitors (8%) . The conclusion of this study is that the most frequently used antihyperglycemia drugs are sulfonylureas (42%) and the least frequently used are a-gluoxidase inhibitors (8%).
Co-Authors Khotimatul Khusna Risma Sakti Pambudi